posted on Jun, 7 2014 @ 09:12 PM
So the GMO giant is at it again. Monsanto has plans to cash in on the new boom in medical marijuana. They plan to patent a genetically modified strain
of the plant for use in the medical field.
Different strains of the marijuana plant contain higher amounts of CBD's
than others and this
non-psychoactive compound has been found to be beneficial to patients suffering from various conditions such as .... Epilepsy, alzhiemers,
schizophrenia, parkinsons, cancer, anxiety and more.
The researchers said the cannabis plant, enriched with CBD, "can be used for treating diseases like rheumatoid arthritis, colitis, liver
inflammation, heart disease and diabetes". Research on CBD enhanced cannabis began in 2009, resulting in Avidekel, a cannabis strain that contains
15.8% CBD and less than 1% THC
Obviously, this new field of research and the developing market is ripe for the picking. And leave it to Monsanto to try and get in on the ground
Uruguay – the first country in the world to officially legalize the production and sale of marijuana. Initiator of the law was the leadership of the
State, headed by President Jose Mujica. According to authorities, a guarantee of success in Uruguay marijuana legalization should be state regulation
of prices for hemp.
There are many reasons why Monsanto and other companies producing GMOs would like to learn a new product. Marijuana may be the next major GMO crop.
First of all, the company plans to produce GMO manipulate so-called “medical marijuana”. If pharmacists join with GMO companies, pharmaceutical
mafia can create transgenic strains with the ability to produce more active compounds which are patented and can be implemented as a medicine.
Personally, I despise companies like Monsanto who high jack Mother nature, patent seeds and try to monopolize farming. Pumping their toxic chemicals
into our environment and buying their way into the legislative branch of our government.
Oh and guess who Monsanto now has as their partner in crime for this new endeavor? None other than billionaire George Soros.
U.S. corporation Monsanto plans to launch production of genetically modified marijuana, and companies such as Drug Policy Alliance y Open Society
Foundation are going to create our own brand, which will be produced under cannabis, information portal La Red 21.
Organization of Open Society Foundation is under the control of the shareholder Monsanto, billionaire George Soros. Company Drug Policy Alliance y
Open Society Foundation, funded by Monsanto will be responsible for market development of transgenic seeds of marijuana, particularly in Uruguay.
What's your opinion on this ATS?
Please remember the follow the T&C rules when discussing this and let's stay on topic